J. S Pharmaceuticals
New Delhi, Delhi
GST No. 07ALFPC8213M1Z3
TrustSEAL Verified
Call 08047800163 84% Response Rate
SEND EMAIL
Product Details:
| Dose Strength | 100 |
| Packaging Size | 10 mg/ml |
| Dosage Form | Solution for Infusion |
| Treatment | Lung Cancer |
| Package Type | Vial |
| Storage | 2-8 degree c |
| Composition | Nivolumab |
Tishtha 100 mg Injection used to treat various cancers, including Metastatic Melanoma, metastatic non-small cell lung cancer, Renal Cell Carcinoma, Hepatocellular carcinoma, Colorectal Cancer, Malignant pleural mesothelioma, Stomach Cancer, Squamous cell carcinoma of head and neck, and Urothelia carcinoma. It contains Nivolumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the action of a programmed death receptor-1 (PD-1), thereby stopping the abnormal growth of cancer cells.
Product Details:
| Dose Strength | 40 |
| Packaging Size | 10 mg/ml |
| Dosage Form | Solution for Infusion |
| Treatment | Lung Cancer |
| Package Type | Vial |
| Storage | 2-8 degree c |
| Shelf Life | 12 month |
| Composition | Nivolumab |
Tishtha 40 mg Injection used to treat various cancers, including Metastatic Melanoma, metastatic non-small cell lung cancer, Renal Cell Carcinoma, Hepatocellular carcinoma, Colorectal Cancer, Malignant pleural mesothelioma, Stomach Cancer, Squamous cell carcinoma of head and neck, and Urothelia carcinoma. It contains Nivolumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the action of a programmed death receptor-1 (PD-1), thereby stopping the abnormal growth of cancer cells.